Cargando…

Late adverse events in patients with pelvic cancer after oncologic treatment—intervention and treatment effect

PURPOSE: Few studies have focused on the late adverse events after oncologic treatment in pelvic cancer patients. Here, the treatment effect/interventions were studied on late side effects as GI, sexual, and urinary symptoms in pelvic cancer patients who visited a highly specialized rehabilitation c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Iselius, Sofia, Knutsen, Annica, Mikiver, Rasmus, Uppugunduri, Srinivas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10102108/ https://www.ncbi.nlm.nih.gov/pubmed/37055633 http://dx.doi.org/10.1007/s00520-023-07733-3

Ejemplares similares

Perception of information to Swedish melanoma patients in routine clinical practice – a cross-sectional survey
por: Tufvesson Stiller, Helena, et al.
Publicado: (2022)

Oncological and surgical outcome after treatment of pelvic sarcomas
por: Puchner, Stephan E., et al.
Publicado: (2017)

Survival after introduction of adjuvant treatment in stage III melanoma: a nationwide registry-based study
por: Helgadottir, Hildur, et al.
Publicado: (2023)

Adverse Events of Oncologic Immunotherapy and Their Management
por: Barber, Fedricker Diane
Publicado: (2019)

Comparison of prothrombin time (INR) results and main characteristics of patients on warfarin treatment in primary health care centers and anticoagulation clinics
por: Arbring, Kerstin, et al.
Publicado: (2013)

Adverse Events During Supervised Exercise Interventions in Pediatric Oncology—A Nationwide Survey
por: Gauß, Gabriele, et al.
Publicado: (2021)

Digitalization of adverse event management in oncology to improve treatment outcome—A prospective study protocol
por: Kestler, Angelika M. R., et al.
Publicado: (2021)

Analysis of late adverse events and their chronological changes after radiation therapy for cervical cancer
por: Yamada, Takehiro, et al.
Publicado: (2018)

Dietary Intervention Improves Gastrointestinal Symptoms after Treatment of Cancer in the Pelvic Organs
por: Borre, Mette, et al.
Publicado: (2023)

Evaluation of urinary continence status and its influence on quality of life after gyneco-oncological treatment of female pelvic malignancies at an oncological center
por: Zafarnia, Maryam, et al.
Publicado: (2022)

Prediction of late adverse events in pelvic cancer patients receiving definitive radiotherapy using radiation-induced gamma-H2AX foci assay
por: Someya, Masanori, et al.
Publicado: (2023)

Reporting adverse events—Swedish Registered Nurses experience in a municipal home care context
por: Pejner, Margaretha Norell, et al.
Publicado: (2018)

Correction to: Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients
por: Zhao, Bin, et al.
Publicado: (2019)

Serious adverse events and fatal adverse events associated with nivolumab treatment in cancer patients: Nivolumab-related serious/fatal adverse events
por: Zhao, Bin, et al.
Publicado: (2018)

Adverse events of methotrexate treatment in JIA
por: in ‘t Veld, J, et al.
Publicado: (2011)

Pelvic colorectal recurrence: crucial role of radiologists in oncologic and surgical treatment options
por: Georgiou, P.A., et al.
Publicado: (2011)

Relationships Among Adverse Events, Disease Characteristics, and Demographics in Treatment of Postherpetic Neuralgia With Gastroretentive Gabapentin
por: Shaparin, Naum, et al.
Publicado: (2015)

Age as a potential predictor of acute side effects during chemoradiotherapy in primary cervical cancer patients
por: Holmqvist, Annica, et al.
Publicado: (2022)

Late Effects of Breast Cancer Treatment and Outcome after Corrective Interventions
por: Pillai, Unni S, et al.
Publicado: (2019)

What can we learn from patient claims? - A retrospective analysis of incidence and patterns of adverse events after orthopaedic procedures in Sweden
por: Öhrn, Annica, et al.
Publicado: (2012)

Endocrine adverse events related to immune-oncology agents: retrospective experience of a single institution
por: España, Sofia, et al.
Publicado: (2020)

Incidence of major adverse cardiovascular events with genotype test guided antiplatelet treatment strategy after percutaneous coronary intervention
por: Ramesh, S., et al.
Publicado: (2020)

Urologic, lymphedema, pelvic pain and gastrointestinal symptoms increase after radiotherapy in patients with primary uterine tumors: a prospective longitudinal Swedish cohort study
por: Holmqvist, A., et al.
Publicado: (2021)

Modeling early haematologic adverse events in conformal and intensity-modulated pelvic radiotherapy in anal cancer
por: Robinson, Maxwell, et al.
Publicado: (2015)

The Adverse Event Unit (AEU): A novel metric to measure the burden of treatment adverse events
por: Hehir, Michael K., et al.
Publicado: (2022)

Segregation analysis of epithelial ovarian cancer in Finland.
por: Auranen, A., et al.
Publicado: (1998)

Late cardiac adverse events in patients with cancer treated with immune checkpoint inhibitors
por: Dolladille, Charles, et al.
Publicado: (2020)

Racial disparities in breast cancer treatment patterns and treatment related adverse events
por: Stabellini, Nickolas, et al.
Publicado: (2023)

Urological involvements in pelvic oncologic surgery
por: Acconcia, A
Publicado: (2010)

Incidental pelvic lesions in the oncology patient
por: Sohaib, S.A., et al.
Publicado: (2011)

Integrating interventional oncology in the treatment of liver tumors
por: Putzer, D., et al.
Publicado: (2018)

Late-onset Pleural and Pericardial Effusion as Immune-related Adverse Events after 94 Cycles of Nivolumab
por: Sawada, Ryo, et al.
Publicado: (2021)

Outcome after Surgical Treatment of Pelvic Sarcomas
por: Han, Ilkyu, et al.
Publicado: (2010)

Modeling Exposure‐Driven Adverse Event Time Courses in Oncology Exemplified by Afatinib
por: Niebecker, Ronald, et al.
Publicado: (2019)

Predictive Factors of Severe Adverse Events in Pediatric Oncologic Patients with Febrile Neutropenia
por: Thangthong, Jutarat, et al.
Publicado: (2020)

SAT471 Hearing-Related Adverse Events in Teprotumumab Oncology Clinical Trials
por: Smith, Terry J, et al.
Publicado: (2023)

Bone sarcoma follow-up; a nationwide analysis of oncological events after initial treatment
por: Goedhart, Louren M., et al.
Publicado: (2022)

Interventional treatments for chronic pelvic pain caused by myometrial cysts
por: Viswanath, Omar, et al.
Publicado: (2019)

Ipilimumab in the treatment of metastatic melanoma: management of adverse events
por: Della Vittoria Scarpati, Giuseppina, et al.
Publicado: (2014)

Adverse events and nocebo phenomena: treatment or disease specific?
por: Zis, Panagiotis, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_5j4admt344c03l4s10t9j1aj31